Unknown

Dataset Information

0

Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences.


ABSTRACT: Importance:Practice guidelines recommend that clinicians engage patients in treatment decisions and explain atherosclerotic cardiovascular disease (ASCVD) risk but do not describe how to communicate this risk most effectively. Objective:To determine how the ASCVD risk time horizon, outcome, and presentation format influence risk perceptions and treatment preferences. Design, Setting, and Participants:From May 27, 2015, through November 12, 2015, participants from the Patient and Provider Assessment of Lipid Management Registry at 140 US cardiology, primary care, and endocrinology practices were presented 3 independent scenarios (representing the same hypothetical patient) and asked to rate their perceived risk and willingness to take medication to lower risk in light of (1) a 15% 10-year ASCVD event risk, (2) a 4% 10-year cardiovascular disease (CVD) death risk, and (3) a 50% lifetime ASCVD event risk. Exposures:Participants were randomized to receive risk estimates using numbers only, a bar graph, or a face pictogram. Results:Of 3566 eligible participants, 2708 (76.9%) responded (median age, 67 years [interquartile range, 61-76 years]; 280 [10.3%] African American; 1491 men [55.1%]). When shown the lifetime ASCVD risk, respondents were more likely to consider the risk "high to very high" than when presented the 10-year ASCVD risk or the CVD death risk (70.1% vs 31.4% vs 25.7%, respectively; both P?

SUBMITTER: Navar AM 

PROVIDER: S-EPMC6551302 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences.

Navar Ann Marie AM   Wang Tracy Y TY   Mi Xiaojuan X   Robinson Jennifer G JG   Virani Salim S SS   Roger Veronique L VL   Wilson Peter W F PWF   Goldberg Anne C AC   Peterson Eric D ED  

JAMA cardiology 20181201 12


<h4>Importance</h4>Practice guidelines recommend that clinicians engage patients in treatment decisions and explain atherosclerotic cardiovascular disease (ASCVD) risk but do not describe how to communicate this risk most effectively.<h4>Objective</h4>To determine how the ASCVD risk time horizon, outcome, and presentation format influence risk perceptions and treatment preferences.<h4>Design, setting, and participants</h4>From May 27, 2015, through November 12, 2015, participants from the Patien  ...[more]

Similar Datasets

| S-EPMC2330036 | biostudies-literature
| S-EPMC6656904 | biostudies-other
| S-EPMC5805247 | biostudies-literature
| S-EPMC6510925 | biostudies-literature
| S-EPMC8385031 | biostudies-literature
| S-EPMC8023822 | biostudies-literature
| S-EPMC7882859 | biostudies-literature
| S-EPMC7786660 | biostudies-literature
| S-EPMC6143261 | biostudies-other
| S-EPMC3377130 | biostudies-literature